Search Results - Kjetil Tasken

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors. by Nora V Lieske, Kristian Tonby, Dag Kvale, Anne M Dyrhol-Riise, Kjetil Tasken

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  2. 2

    Acta Oncologica Nordic Precision Cancer Medicine Symposium 2023 – merging clinical research and standard healthcare by Elisa Bjørgo, Gro L. Fagereng, Hege G. Russnes, Sigbjørn Smeland, Kjetil Taskén, Åslaug Helland

    Published in Acta Oncologica (2024-06-01)
    Get full text
    Article


  3. 3

    The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection by Kristian Tonby, Ida Wergeland, Nora V. Lieske, Dag Kvale, Kjetil Tasken, Anne M. Dyrhol-Riise

    Published in BMC Infectious Diseases (2016-10-01)
    Get full text
    Article


  4. 4

    Enhanced Gut-Homing Dynamics and Pronounced Exhaustion of Mucosal and Blood CD4+ T Cells in HIV-Infected Immunological Non-Responders by Kristina Berg Lorvik, Kristina Berg Lorvik, Kristina Berg Lorvik, Malin Holm Meyer-Myklestad, Malin Holm Meyer-Myklestad, Kushi Kushekar, Kushi Kushekar, Charlotte Handeland, Asle Wilhelm Medhus, Marius Lund-Iversen, Birgitte Stiksrud, Dag Kvale, Dag Kvale, Anne Margarita Dyrhol-Riise, Anne Margarita Dyrhol-Riise, Kjetil Taskén, Kjetil Taskén, Kjetil Taskén, Dag Henrik Reikvam, Dag Henrik Reikvam

    Published in Frontiers in Immunology (2021-10-01)
    Get full text
    Article


  5. 5

    Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients by Marthe Jøntvedt Jørgensen, Marthe Jøntvedt Jørgensen, Kristin G. Nore, Hans Christian D. Aass, Emilie Layre, Jérôme Nigou, Rasmus Mortensen, Kjetil Tasken, Kjetil Tasken, Dag Kvale, Synne Jenum, Kristian Tonby, Kristian Tonby, Anne Ma Dyrhol-Riise, Anne Ma Dyrhol-Riise

    Get full text
    Article


  6. 6

    The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity by Elise Solli, Alessio Bevilacqua, Mathias Wenes, Denis Migliorini, Lars van derVeen, Sigrid S Skånland, Giusy Di Conza, Kjetil Taskén

    Published in Molecular Oncology (2026-06-01)
    Get full text
    Article


  7. 7

    Patient‐derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways by Katharina Bischof, Andrea Cremaschi, Lena Eroukhmanoff, Johannes Landskron, Lise‐Lotte Flage‐Larsen, Alexandra Gade, Line Bjørge, Alfonso Urbanucci, Kjetil Taskén

    Published in Molecular Oncology (2025-01-01)
    Get full text
    Article


  8. 8

    Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells by Anna Parente-Ribes, Sigrid S. Skånland, Simone Bürgler, Audun Os, Dong Wang, Bjarne Bogen, Geir E. Tjønnfjord, Kjetil Taskén, Ludvig A. Munthe

    Published in Haematologica (2016-02-01)
    Get full text
    Article


  9. 9

    Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial. by Christian Prebensen, Marius Trøseid, Thor Ueland, Anders Dahm, Per Morten Sandset, Ingeborg Aaberge, Kristian Waalen, Anne Ma Dyrhol-Riise, Kjetil Taskén, Dag Kvale

    Published in PLoS ONE (2017-01-01)
    Get full text
    Article


  10. 10

    C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease. by Johannes Landskron, Sigrid M Kraggerud, Elisabeth Wik, Anne Dørum, Merete Bjørnslett, Espen Melum, Øystein Helland, Line Bjørge, Ragnhild A Lothe, Helga B Salvesen, Kjetil Taskén

    Published in PLoS ONE (2017-01-01)
    Get full text
    Article


  11. 11

    A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine by Johanne U. Hermansen, Yanping Yin, Aleksandra Urban, Camilla V. Myklebust, Linda Karlsen, Katrine Melvold, Anders A. Tveita, Kjetil Taskén, Ludvig A. Munthe, Geir E. Tjønnfjord, Sigrid S. Skånland

    Published in Cell Death Discovery (2023-04-01)
    Get full text
    Article


  12. 12

    P613: ANALYSIS OF EX-VIVO RESPONSE TO SINGLE DRUGS AND DRUG COMBINATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENT SAMPLES by Leonardo Miranda Santana, Deepak B. Thimiri Govinda Raj, Andrea Cremaschi, Mariaserena Giliberto, Alexandra Gade, Arnoldo Frigessi, Geir E. Tjønnfjord, Ludvig A. Munthe, Sigrid S. Skånland, Manuela Zucknick, Kjetil Taskén

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  13. 13

    Standardized assays to monitor drug sensitivity in hematologic cancers by Pilar Ayuda-Durán, Johanne U. Hermansen, Mariaserena Giliberto, Yanping Yin, Robert Hanes, Sandra Gordon, Heikki Kuusanmäki, Andrea M. Brodersen, Aram N. Andersen, Kjetil Taskén, Krister Wennerberg, Jorrit M. Enserink, Sigrid S. Skånland

    Published in Cell Death Discovery (2023-12-01)
    Get full text
    Article


  14. 14

    Evolutionary mode and timing of dissemination of high-grade serous carcinomas by Anita Sveen, Bjarne Johannessen, Solveig M.K. Klokkerud, Sigrid M. Kraggerud, Leonardo A. Meza-Zepeda, Merete Bjørnslett, Katharina Bischof, Ola Myklebost, Kjetil Taskén, Rolf I. Skotheim, Anne Dørum, Ben Davidson, Ragnhild A. Lothe

    Published in JCI Insight (2024-02-01)
    Get full text
    Article


  15. 15

    The effect of HLA genotype on disease onset and severity in CTLA-4 insufficiency by Sara Posadas-Cantera, Sara Posadas-Cantera, Noriko Mitsuiki, Florian Emmerich, Virginia Patiño, Hanns-Martin Lorenz, Olaf Neth, Ingunn Dybedal, Kjetil Taskén, Alejandro A. Schäffer, Bodo Grimbacher, Bodo Grimbacher, Bodo Grimbacher, Bodo Grimbacher, Laura Gámez-Díaz, Laura Gámez-Díaz

    Published in Frontiers in Immunology (2025-01-01)
    Get full text
    Article


  16. 16

    IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results by Katarina Puco, Gro Live Fagereng, Sigmund Brabrand, Pitt Niehusmann, Egil Støre Blix, Eli Sihn Samdal Steinskog, Åse Haug, Cecilie Fredvik Torkildsen, Irja Alida Oppedal, Sebastian Meltzer, Åsmund Flobak, Kajsa Anna Margareta Johansson, Line Bjørge, Geir Olav Hjortland, Astrid Dalhaug, Jo-Åsmund Lund, Bjørnar Gilje, Marte Grønlie Cameron, Randi Hovland, Ragnhild S. Falk, Sigbjørn Smeland, Hege Elisabeth Giercksky Russnes, Kjetil Taskén, Åslaug Helland

    Published in Acta Oncologica (2024-05-01)
    Get full text
    Article


  17. 17

    T cells with increased responsiveness cause obesity in mice without diet intervention by Ida Gregersen, Xiang Y. Kong, Sander Kooijman, Håvard Foyn, Helene Grannes, Maria B. Olsen, Anna M. Lone, Kuan Yang, Ana Quiles-Jiménez, Marianne Tran, Jonas Øgaard, Filip M. Segers, Azita Rashidi, Ellen Lund Sagen, Knut H. Lauritzen, Amanda C.M. Pronk, Jan Freark de Boer, Kirsten B. Holven, Espen Melum, Pål Aukrust, Kjetil Taskén, Sverre Holm, Patrick C.N. Rensen, Tuva B. Dahl, Bente Halvorsen

    Published in iScience (2024-04-01)
    Get full text
    Article


  18. 18

    PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe by Kjetil Taskén, Soemeya F. Haj Mohammad, Gro Live Fagereng, Ragnhild Sørum Falk, Åslaug Helland, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Katarina Steen Carlsson, Bettina Ryll, Katriina Jalkanen, Anders Edsjö, Hege G. Russnes, Ulrik Lassen, Ebba Hallersjö Hult, Iwona Lugowska, Jean-Yves Blay, Loic Verlingue, Edvard Abel, Maeve A. Lowery, Matthew G. Krebs, Kristoffer Staal Rohrberg, Kristiina Ojamaa, Julio Oliveira, Henk M.W. Verheul, Emile E. Voest, Hans Gelderblom

    Published in Acta Oncologica (2024-05-01)
    Get full text
    Article


  19. 19

    Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway by Åslaug Helland, Hege G. Russnes, Gro Live Fagereng, Khalid Al-Shibli, Yvonne Andersson, Thomas Berg, Line Bjørge, Egil Blix, Bodil Bjerkehagen, Sigmund Brabrand, Marte Grønlie Cameron, Astrid Dalhaug, Dalia Dietzel, Tom Dønnem, Espen Enerly, Åsmund Flobak, Sverre Fluge, Bjørnar Gilje, Bjørn Tore Gjertsen, Bjørn Henning Grønberg, Kari Grønås, Tormod Guren, Hanne Hamre, Åse Haug, Daniel Heinrich, Geir Olav Hjortland, Eivind Hovig, Randi Hovland, Ann-Charlotte Iversen, Emiel Janssen, Jon Amund Kyte, Hedda von der Lippe Gythfeldt, Ragnhild Lothe, Jo-Åsmund Lund, Leonardo Meza-Zepeda, Monica Cheng Munthe-Kaas, Olav Toai Duc Nguyen, Pitt Niehusmann, Hilde Nilsen, Katarina Puco, Anne Hansen Ree, Tonje Bøyum Riste, Karin Semb, Eli Sihn Samdal Steinskog, Andreas Stensvold, Pål Suhrke, Øyvind Tennøe, Geir E. Tjønnfjord, Liv Jorunn Vassbotn, Eline Aas, Kristine Aasebø, Kjetil Tasken, Sigbjørn Smeland

    Published in Journal of Translational Medicine (2022-07-01)
    Get full text
    Article


Search Tools: